Dimensional Fund Advisors
LXEO icon

Dimensional Fund Advisors’s Lexeo Therapeutics LXEO Stock Holding History

Dimensional Fund Advisors’s Portfolio LXEO Stock Details LXEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.33M Buy
1,103,584
+240,692
+28% +$1.71M ﹤0.01% 2421
2025
Q4 		$8.57M Sell
862,892
-49,641
-5% -$453K ﹤0.01% 2339
2025
Q3 		$6.06M Buy
912,533
+865,510
+1,841% +$4.19M ﹤0.01% 2485
2025
Q2 		$189K Buy
+47,023
New +$155K ﹤0.01% 3122

Other funds holding LXEO

PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors's LXEO Position: Q1 2026 in Review

Dimensional Fund Advisors increased its Lexeo Therapeutics (LXEO) stake by 28% in Q1 2026, buying an estimated $1.71M and bringing the position to 1,103,584 shares worth $6.33M. The position accounts for ﹤0.01% of the portfolio, ranked #2421.

Dimensional Fund Advisors first reported a position in LXEO in Q2 2025 and has held it in 4 quarters since. The position peaked at $8.57M in Q4 2025. 139 funds tracked by Wall St. Rank hold LXEO as of Q1 2026.

  • Dimensional Fund Advisors held 1,103,584 shares of Lexeo Therapeutics worth $6.33M as of Q1 2026.
  • Dimensional Fund Advisors bought 240,692 Lexeo Therapeutics shares in Q1 2026, an estimated $1.71M.
  • Lexeo Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2421 holding.
  • Dimensional Fund Advisors first reported a position in Lexeo Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • Dimensional Fund Advisors's Lexeo Therapeutics position peaked at $8.57M in Q4 2025.
  • 139 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.